ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 254 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $816,848 | -26.6% | 30,400 | -2.6% | 0.02% | -24.0% |
| Q2 2023 | $1,112,592 | +52.6% | 31,200 | +8.7% | 0.02% | +38.9% |
| Q1 2023 | $728,980 | +63400.0% | 28,700 | +1.4% | 0.02% | -41.9% |
| Q4 2022 | $1,148 | -99.9% | 28,300 | +0.4% | 0.03% | +14.8% |
| Q3 2022 | $932,000 | -21.4% | 28,200 | +1.4% | 0.03% | -15.6% |
| Q2 2022 | $1,186,000 | -6.1% | 27,800 | +0.7% | 0.03% | +6.7% |
| Q1 2022 | $1,263,000 | -28.9% | 27,600 | +3.0% | 0.03% | -23.1% |
| Q4 2021 | $1,777,000 | +7.0% | 26,800 | +0.8% | 0.04% | -2.5% |
| Q3 2021 | $1,661,000 | -25.7% | 26,600 | -1.5% | 0.04% | -25.9% |
| Q2 2021 | $2,236,000 | +24.9% | 27,000 | 0.0% | 0.05% | +14.9% |
| Q1 2021 | $1,790,000 | -9.2% | 27,000 | +5.1% | 0.05% | -17.5% |
| Q4 2020 | $1,972,000 | +79.6% | 25,700 | +0.8% | 0.06% | +11.8% |
| Q3 2020 | $1,098,000 | +0.1% | 25,500 | +0.4% | 0.05% | -21.5% |
| Q2 2020 | $1,097,000 | +57.6% | 25,400 | +5.0% | 0.06% | +27.5% |
| Q1 2020 | $696,000 | -54.7% | 24,200 | 0.0% | 0.05% | -32.9% |
| Q4 2019 | $1,535,000 | +54.7% | 24,200 | -31.2% | 0.08% | +46.2% |
| Q3 2019 | $992,000 | +3.5% | 35,200 | -0.3% | 0.05% | +8.3% |
| Q2 2019 | $958,000 | – | 35,300 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,346 | $62,945,000 | 41.38% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $250,206,000 | 32.27% |
| Aquilo Capital Management, LLC | 365,926 | $28,078,000 | 5.84% |
| L1 Capital Pty Ltd | 298,687 | $23,127,000 | 4.32% |
| First Light Asset Management, LLC | 704,449 | $54,052,000 | 4.00% |
| ACUTA CAPITAL PARTNERS, LLC | 139,000 | $10,665,000 | 2.90% |
| Evolutionary Tree Capital Management, LLC | 48,265 | $3,703,000 | 2.82% |
| Parkman Healthcare Partners LLC | 127,171 | $9,758,000 | 2.50% |
| Capital Impact Advisors, LLC | 88,183 | $6,766,000 | 1.66% |
| Tri Locum Partners LP | 56,003 | $4,297,000 | 1.56% |